Neuronetics (STIM) Net Income towards Common Stockholders (2017 - 2026)

Neuronetics (STIM) has 10 years of Net Income towards Common Stockholders data on file, last reported at -$11.3 million in Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 13.96% year-over-year to -$11.3 million in Q1 2026; TTM through Mar 2026 was -$48.2 million, a 4.93% decrease from a year earlier, with the FY2025 full-year figure at -$39.9 million, up 76.36% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$11.3 million, down from -$6.6 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for STIM reached as high as -$6.1 million in Q4 2023 and fell as low as -$18.2 million in Q2 2025.
• Historically, Net Income towards Common Stockholders has averaged -$10.8 million across 5 years, with a median of -$10.1 million in 2024.
• Across the five-year window, Net Income towards Common Stockholders surged 56.22% in 2022 and tumbled 116.98% in 2024, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$9.5 million in 2022, then jumped by 35.67% to -$6.1 million in 2023, then sank by 116.98% to -$13.2 million in 2024, then surged by 49.97% to -$6.6 million in 2025, then plunged by 70.13% to -$11.3 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$11.3 million in Q1 2026, -$6.6 million in Q4 2025, and -$12.1 million in Q3 2025.